| 21 |
|
Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers/
|
Kawana, K
|
Butterworths
|
2003
|
|
|
|
| 22 |
|
Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers
|
Von Specht, B.-U
|
Butterworths
|
1996
|
|
|
|
| 23 |
|
Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age
|
Greenberg, D. P
|
Butterworths
|
1996
|
|
|
|
| 24 |
|
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60
|
Falsey, A. R
|
Butterworths
|
1996
|
|
|
|
| 25 |
|
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly
|
Falsey, A. R
|
Butterworths
|
1997
|
|
|
|
| 26 |
|
Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults
|
Kotloff, K. L
|
Butterworths
|
1996
|
|
|
|
| 27 |
|
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children/
|
Genton, B
|
Butterworths
|
2003
|
|
|
|
| 28 |
|
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12
|
Bernstein, D. I
|
Butterworths
|
1998
|
|
|
|
| 29 |
|
Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants/
|
Clements-Mann, Mary Lou
|
Butterworths
|
2001
|
|
|
|
| 30 |
|
Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults
|
Briggs, D. J
|
Butterworths
|
1996
|
|
|
|
| 31 |
|
Safety and immunogenicity of REMUNE^T^m in HIV-infected Thai subjects
|
Limsuwan, A
|
Butterworths
|
1998
|
|
|
|
| 32 |
|
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women/
|
Munoz, F. M
|
Butterworths
|
2003
|
|
|
|
| 33 |
|
Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors/
|
Jackson, Lisa A
|
Butterworths
|
2001
|
|
|
|
| 34 |
|
Safety and protective efficacy of porcine reproductive and respiratory syndrome recombinant virus vaccines in young pigs/
|
Verheije, M. H
|
Butterworths
|
2003
|
|
|
|
| 35 |
|
Safety, efficacy, and immunogenicity of a recombinant Osp subunit canineLyme disease vaccine
|
Ma, J
|
Butterworths
|
1996
|
|
|
|
| 36 |
|
Safety of Haemophilus influenzae conjugate vaccine in children born to HIV-1 infected mothers: Kigali (Rwanda), 1992-1994
|
Leroy, V
|
Butterworths
|
1997
|
|
|
|
| 37 |
|
Safety study of the SAG~2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe
|
Masson, E
|
Butterworths
|
1996
|
|
|
|
| 38 |
|
Sales law and the negotiability of motor vehicles: a legal conundrum
|
Davies, I. R
|
Butterworths
|
1995
|
|
|
|
| 39 |
|
Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles
|
Challacombe, S. J
|
Butterworths
|
1997
|
|
|
|
| 40 |
|
Salmonella DNA adenine methylase mutants elicit early and late onset protective immune responses in calves/
|
Dueger, E. L
|
Butterworths
|
2003
|
|
|
|
